FrancisMSenecalMD

PubMed

• 18 citations
  Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With SomaticMutations.
  Priscilla K Brastianos, Erin L Twohy, Elizabeth R Gerstner, Timothy J Kaufmann, A John Iafrate, Jochen Lennerz, Suriya Jeyapalan, David E Piccioni, Varun Monga, Camilo...> ;Journal of Clinical Oncology. 2023 Jan 20
• 1 citations
  Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Can...
  Kimberly A Burton, Elisabeth Mahen, Eric Quentin Konnick, Sibel Blau, Michael O Dorschner, Arturo B Ramirez, Stephen C Schmechel, Chaozhong Song, Rahul Parulkar, Steph...> ;JCO Precision Oncology. 2022 Mar 1
• 119 citations
  Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
  Arlene Chan, Beverly Moy, Janine Mansi, Bent Ejlertsen, Frankie A. Holmes, Stephen Chia, Hiroji Iwata, Michael Gnant, Sibylle Loibl, Carlos H. Barrios, Isil Somali, Sn...> ;Clinical Breast Cancer. 2021 Feb 1
• Effects of Neratinib on Health-Related Quality-of-Life in Women with HER2-Positive Early-Stage Breast Cancer: Longitudinal Analyses from the Randomized Phase III ExteN...
  Delaloge, S.,Cella, D.,Ye, Y.,Buyse, M.,Chan, A.,Barrios, C. H.,Holmes, F. A.,Mansi, J.,Iwata, H.,Ejlertsen, B.,Moy, B.,Chia, SKL.,Gnant, M.,Smichkoska, S.,Ciceniene, ...> ;Ann. Oncol.. 2019 Jan 29
• 3 citations
  Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical ...
  Emiliano Calvo, Analia Azaro, Jordi Rodon, Luc Dirix, Manon T. Huizing, Francis Mark Senecal, Patricia LoRusso, Lorrin K. Yee, Italo Poggesi, Jan de Jong, Spyros Trian...> ;Investigational New Drugs. 2018 Jun 1
• 3 citations
  Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breas...
  Nicole M. Kuderer, Kimberly A. Burton, Sibel Blau, Francis M. Senecal, Vijayakrishna K. Gadi, S Parker, Elisabeth Mahen, David Veenstra, Josh J. Carlson, Gary H. Lyman...> ;JCO Precision Oncology. 2017 Aug 16
• 8 citations
  The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40
  Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer, Christine K. Zoon, Kelley M. Kidwell, André Robidoux, Luis Baez-Diaz, Adam Brufsky, Rita S. Mehta, Louis Feh...> ;Annals of Surgical Oncology. 2017 Jul 1
• 16 citations
  A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer
  C. Anthony Blau, Arturo Ramirez, Sibel Blau, Colin C. Pritchard, Michael O. Dorschner, Stephen C. Schmechel, Timothy J. Martins, Elisabeth Mahen, Kimberly A. Burton, V...> ;Journal of the National Comprehensive Cancer Network. 2016 Jan 1
• 109 citations
  Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial
  Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer, Qing Liu, André Robidoux, Luis Baez-Diaz, Adam Brufsky, Rita S. Mehta, Louis Fehrenbacher, James A. Young, F...> ;The Lancet. Oncology. 2015 Sep 1
• 325 citations
  Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
  Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer, André Robidoux, James N. Atkins, Luis Baez-Diaz, Adam Brufsky, Rita S. Mehta, Louis Fehrenbacher, James A. Y...> ;The New England Journal of Medicine. 2012 Jan 25
• The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40.
  Bear HD, Tang G, Rastogi P, Geyer CE, Robidoux A, Atkins JN, Baez L, Brufsky A, Mehta RS, Fehrenbacher L, Pajon ER, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross H...> ;J. Clin. Oncol.. 2011-06-20
• The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40.
  Bear HD, Tang G, Rastogi P, Geyer CE, Robidoux A, Atkins JN, Baez L, Brufsky A, Mehta RS, Fehrenbacher L, Pajon ER, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross H...> ;J. Clin. Oncol.. 2011-05-20
• 596 citations
  Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
  David J. Kuter, James B. Bussel, Roger M. Lyons, Vinod Pullarkat, Terry Gernsheimer, Francis M. Senecal, Louis M. Aledort, James N. George, Craig M. Kessler, Miguel A....> ;Lancet. 2008 Feb 2
• 202 citations
  The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro.
  John M. Harlan, Paul D. Killen, Frank M. Senecal, Barbara R. Schwartz, Esther Yee, Robert F. Taylor, Patrick G. Beatty, Thomas H. Price, Hans D. Ochs> ;Blood. 1985 Jul 1
• Gastric chloroma associated with upper gastrointestinal tract bleeding.
  Priebe, W. M., Senecal, F. M.> ;Gastrointest Endosc. 1991 Jul 01
• Busulfan clearance in renal failure and hemodialysis.
  Ullery, L. L., Gibbs, J. P., Ames, G. W., Senecal, F. M., Slattery, J. T.> ;Bone Marrow Transplant. 2000 Jan
• Join now to see all